Sen-Jam Pharmaceutical Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Crowdfunding

  • Latest Deal Amount
  • $3.36M

  • Investors
  • 5

Sen-Jam Pharmaceutical General Information

Description

Developer of anti-inflammatory therapeutics intended to address chronic inflammation and metabolic disorders. The company's technology utilizes proprietary pleiotropic anti-inflammatory regulators and molecular repurposing to produce non-opioid combination therapeutics, enabling the treatment of viral respiratory infections, opioid withdrawal, and alcohol-induced inflammatory responses.

Contact Information

Website
www.sen-jam.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 223 Wall Street
  • Suite 130
  • Huntington, NY 11743
  • United States
+1 (201)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Corporate Office
  • 223 Wall Street
  • Suite 130
  • Huntington, NY 11743
  • United States
+1 (201)

Sen-Jam Pharmaceutical Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sen-Jam Pharmaceutical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Equity Crowdfunding 01-Apr-2025 $3.36M Completed Clinical Trials - Phase 2
11. Later Stage VC 22-Jan-2025 Completed Clinical Trials - Phase 2
10. Later Stage VC 07-Mar-2024 Completed Clinical Trials - Phase 2
9. Later Stage VC 11-Jul-2023 Completed Clinical Trials - Phase 2
8. Later Stage VC 26-Apr-2023 Completed Clinical Trials - Phase 2
7. Equity Crowdfunding 12-Jan-2023 Completed Clinical Trials - Phase 2
6. Later Stage VC 15-Sep-2022 Completed Clinical Trials - Phase 2
5. Equity Crowdfunding 01-Aug-2022 Completed Clinical Trials - Phase 2
4. Later Stage VC 16-Mar-2022 $3M $6.19M Completed Clinical Trials - Phase 2
3. Early Stage VC 31-Oct-2021 $3M $3.19M Completed Clinical Trials - Phase 1
To view Sen-Jam Pharmaceutical’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Sen-Jam Pharmaceutical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of anti-inflammatory therapeutics intended to address chronic inflammation and metabolic disorders. The compan
Drug Discovery
Huntington, NY
8 As of 2024

Stockholm, Sweden
 

Burlington, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Sen-Jam Pharmaceutical Competitors (14)

One of Sen-Jam Pharmaceutical’s 14 competitors is Gesynta Pharma, a Venture Capital-Backed company based in Stockholm, Sweden.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Gesynta Pharma Venture Capital-Backed Stockholm, Sweden
Cardurion Venture Capital-Backed Burlington, MA
Ability Pharma Private Equity-Backed Cerdanyola, Spain
Pfizer (Vienna) Corporation Vienna, Austria
Gilead Formerly VC-backed Foster City, CA
You’re viewing 5 of 14 competitors. Get the full list »

Sen-Jam Pharmaceutical Patents

Sen-Jam Pharmaceutical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026136641-A1 Compositions and methods for treatment of obesity and metabolic disorders Pending 18-Dec-2024
AU-2025245512-A1 Pharmaceutical formulations and manufacturing processes Pending 29-Mar-2024
WO-2025208003-A1 Pharmaceutical formulations and manufacturing processes Pending 29-Mar-2024
AU-2024398129-A1 Methods and compositions for treating liver disease Pending 12-Dec-2023
EP-4823575-A1 Methods and compositions for treating liver disease Pending 12-Dec-2023 A61P1/16
To view Sen-Jam Pharmaceutical’s complete patent history, request access »

Sen-Jam Pharmaceutical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sen-Jam Pharmaceutical Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel (individual)
Angel (individual)
5 Horizons Capital Venture Capital Minority
Opus8 PE/Buyout Minority
Angel (individual) Minority
To view Sen-Jam Pharmaceutical’s complete investors history, request access »

Sen-Jam Pharmaceutical FAQs

  • When was Sen-Jam Pharmaceutical founded?

    Sen-Jam Pharmaceutical was founded in 2017.

  • Where is Sen-Jam Pharmaceutical headquartered?

    Sen-Jam Pharmaceutical is headquartered in Huntington, NY.

  • What is the size of Sen-Jam Pharmaceutical?

    Sen-Jam Pharmaceutical has 8 total employees.

  • What industry is Sen-Jam Pharmaceutical in?

    Sen-Jam Pharmaceutical’s primary industry is Drug Discovery.

  • Is Sen-Jam Pharmaceutical a private or public company?

    Sen-Jam Pharmaceutical is a Private company.

  • What is the current valuation of Sen-Jam Pharmaceutical?

    The current valuation of Sen-Jam Pharmaceutical is .

  • What is Sen-Jam Pharmaceutical’s current revenue?

    The current revenue for Sen-Jam Pharmaceutical is .

  • How much funding has Sen-Jam Pharmaceutical raised over time?

    Sen-Jam Pharmaceutical has raised $15.2M.

  • Who are Sen-Jam Pharmaceutical’s investors?

    , , 5 Horizons Capital, Opus8, and have invested in Sen-Jam Pharmaceutical.

  • Who are Sen-Jam Pharmaceutical’s competitors?

    Gesynta Pharma, Cardurion, Ability Pharma, Pfizer (Vienna), and Gilead are some of the 14 competitors of Sen-Jam Pharmaceutical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process